Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Weidenbecher is active.

Publication


Featured researches published by Mark Weidenbecher.


Laryngoscope | 2008

Fabrication of a Neotrachea Using Engineered Cartilage

Mark Weidenbecher; Harvey M. Tucker; Amad Awadallah; James E. Dennis

Objectives: Surgical management of long‐segment tracheal stenosis is an ongoing problem. Many types of tracheal prostheses have been tried but with limited success because of immune rejection, graft ischemia, or restenosis. Tissue engineered cartilage may offer a solution to this problem, although scaffolds, which are currently often used for support, can lead to biocompatibility problems. This study investigated the feasibility of scaffold‐free cartilage to tissue engineer a vascularized neotrachea in rabbits.


Laryngoscope | 2007

Hyaluronan-based scaffolds to tissue-engineer cartilage implants for laryngotracheal reconstruction

Mark Weidenbecher; James H. Henderson; Harvey M. Tucker; Jonathan Z. Baskin; Amad Awadallah; James E. Dennis

Objectives: Donor site morbidity, including pneumothorax, can be a considerable problem when harvesting cartilage grafts for laryngotracheal reconstruction (LTR). Tissue‐engineered cartilage may offer a solution to this problem. This study investigated the feasibility of using Hyalograft C combined with autologous chondrocytes to tissue engineer cartilage grafts for LTR in rabbits.


BioResearch Open Access | 2012

Methods for Producing Scaffold-Free Engineered Cartilage Sheets from Auricular and Articular Chondrocyte Cell Sources and Attachment to Porous Tantalum

G. Adam Whitney; Hisashi Mera; Mark Weidenbecher; Amad Awadallah; Joseph M. Mansour; James E. Dennis

Abstract Scaffold-free cartilage engineering techniques may provide a simple alternative to traditional methods employing scaffolds. We previously reported auricular chondrocyte-derived constructs for use in an engineered trachea model; however, the construct generation methods were not reported in detail. In this study, methods for cartilage construct generation from auricular and articular cell sources are described in detail, and the resulting constructs are compared for use in a joint resurfacing model. Attachment of cartilage sheets to porous tantalum is also investigated as a potential vehicle for future attachment to subchondral bone. Large scaffold-free cartilage constructs were produced from culture-expanded chondrocytes from skeletally mature rabbits, and redifferentiated in a chemically-defined culture medium. Auricular constructs contained more glycosaminoglycan (39.6±12.7 vs. 9.7±1.9 μg/mg wet weight, mean and standard deviation) and collagen (2.7±0.45 vs. 1.1±0.2 μg/mg wet weight, mean and standard deviation) than articular constructs. Aggregate modulus was also higher for auricular constructs vs. articular constructs (0.23±0.07 vs. 0.12±0.03 MPa, mean and standard deviation). Attachment of constructs to porous tantalum was achieved by neocartilage ingrowth into tantalum pores. These results demonstrate that large scaffold-free neocartilage constructs can be produced from mature culture-expanded chondrocytes in a chemically-defined medium, and that these constructs can be attached to porous tantalum.


Journal of Neurosurgery | 2013

Prevention of postoperative cerebrospinal fluid leaks with multilayered reconstruction using titanium mesh–hydroxyapatite cement cranioplasty after translabyrinthine resection of acoustic neuroma

Sunil Manjila; Mark Weidenbecher; Maroun T. Semaan; Cliff A. Megerian; Nicholas C. Bambakidis

OBJECT Several prophylactic surgical methods have been tried to prevent CSF leakage after translabyrinthine resection of acoustic neuroma (TLAN). The authors report an improvised technique for multilayer watertight closure using titanium mesh-hydroxyapatite cement (HAC) cranioplasty in addition to dural substitute and abdominal fat graft after TLAN. METHODS The study was limited to 42 patients who underwent TLAN at University Hospitals Case Medical Center using this new technique from 2006 to 2012. Systematic closure of the surgical wound in layers using temporalis fascia, dural substitute, dural sealant, adipose graft, titanium mesh, and then HAC was performed in each case. Temporalis muscle and eustachian tube obliteration were not used. The main variables studied were patient age, tumor size, tumor location, cosmetic outcome, length of hospitalization, and the incidence of CSF leak, pseudomeningocele, and infection. RESULTS Excellent cosmetic outcome was achieved in all patients. There were no cases of postoperative CSF rhinorrhea, incisional CSF leak, or meningitis. Cosmetic results were comparable to those achieved using HAC alone. This cost-effective technique used only a third of the HAC required for traditional closure in which the entire mastoid defect is filled with cement, predisposing to infection. Postoperative CT and MRI showed excellent bony contouring and dural reconstitution, respectively. CONCLUSIONS The authors report on successful use of titanium mesh-HAC cranioplasty in preventing postoperative CSF leak after TLAN in all cases in their series. The titanium mesh provides a well-defined anatomical dissection plane that would make reoperation easier than working through scarred soft tissue. The mesh bolsters the fat graft and keeps HAC out of direct contact with mastoid air cells, thereby reducing the risk of infection. The cement cranioplasty does not preclude subsequent implantation of a bone-anchored hearing aid.


Otolaryngology-Head and Neck Surgery | 2018

Upper Airway Stimulation for Obstructive Sleep Apnea: Results from the ADHERE Registry:

Maurits Boon; Colin Huntley; Armin Steffen; Joachim T. Maurer; J. Ulrich Sommer; Richard J. Schwab; Erica R. Thaler; Ryan J. Soose; Courtney Chou; Patrick J. Strollo; Eric J. Kezirian; Stanley H. Chia; Kirk P. Withrow; Mark Weidenbecher; Kingman P. Strohl; Karl Doghramji; Benedikt Hofauer; Clemens Heiser

Objective Upper airway stimulation (UAS) is an alternative treatment option for patients unable to tolerate continuous positive airway pressure (CPAP) for the treatment of obstructive sleep apnea (OSA). Studies support the safety and efficacy of this therapy. The aim of this registry is to collect retrospective and prospective objective and subjective outcome measures across multiple institutions in the United States and Germany. To date, it represents the largest cohort of patients studied with this therapy. Study Design Retrospective and prospective registry study. Setting Ten tertiary care hospitals in the United States and Germany. Subjects and Methods Patients were included who had moderate to severe OSA, were intolerant to CPAP, and were undergoing UAS implantation. Baseline demographic and sleep study data were collected. Objective and subjective treatment outcomes, adverse events, and patient and physician satisfaction were reviewed. Results The registry enrolled 301 patients between October 2016 and September 2017. Mean ± SD AHI decreased from 35.6 ± 15.3 to 10.2 ± 12.9 events per hour (P < .0001), and Epworth Sleepiness Scale scores decreased from 11.9 ± 5.5 to 7.5 ± 4.7 (P < .0001) from baseline to the posttitration visit. Patients utilized therapy for 6.5 hours per night. There were low rates of procedure- and device-related complications. Clinical global impression scores demonstrated that the majority of physicians (94%) saw improvement in their patients’ symptoms with therapy. The majority of patients (90%) were more satisfied with UAS than CPAP. Conclusions Across a multi-institutional registry, UAS therapy demonstrates significant improvement in subjective and objective OSA outcomes, good therapy adherence, and high patient satisfaction.


Respiratory investigation | 2016

Origins of and implementation concepts for upper airway stimulation therapy for obstructive sleep apnea

Kingman P. Strohl; Jonathan Z. Baskin; Colleen Lance; Diana Ponsky; Mark Weidenbecher; B.A. Madeleine Strohl; Motoo Yamauchi

Upper airway stimulation, specifically hypoglossal (CN XII) nerve stimulation, is a new, alternative therapy for patients with obstructive sleep apnea hypopnea syndrome who cannot tolerate positive airway pressure, the first-line therapy for symptomatic patients. Stimulation therapy addresses the cause of inadequate upper airway muscle activation for nasopharyngeal and oropharyngeal airway collapse during sleep. The purpose of this report is to outline the development of this first-in-class therapy and its clinical implementation. Another practical theme is assessment of the features for considering a surgically implanted device and the insight as to how both clinical and endoscopic criteria increase the likelihood of safe and durable outcomes for an implant and how to more generally plan for management of CPAP-intolerant patients. A third theme is the team building required among sleep medicine and surgical specialties in the provision of individualized neurostimulation therapy.


American Journal of Otolaryngology | 2017

Laryngeal alveolar soft part sarcoma: A case report of a rare malignancy in an atypical location☆

Akina Tamaki; Jay Wasman; Mark Weidenbecher

Laryngeal sarcoma is a rare and potentially aggressive malignancy. In this case report, we present a 23year-old-male with four-years of progressive hoarseness who was found to have a large left paraglottic mass. A partial laryngectomy was successful at completely excising the lesion. Final pathology returned as alveolar soft part sarcoma. Alveolar soft part sarcomas of the larynx are extremely rare with only five cases published in the current literature. This article provides a case presentation with literature review of alveolar soft part sarcoma of the head and neck.


Laryngoscope | 2018

Repair of high-grade posterior glottic stenosis: A novel criocarytenoid joint release technique: Repair of Posterior Glottic Stenosis

Mark Weidenbecher

INTRODUCTION Intubation injury is the most common cause of posterior glottic stenosis (PGS). Bogdasarian has classified PGS into four types. In particular, type 3 and 4 PGS, which include dense interarytenoid scar and ankylosis of one or both cricoarytenoid joints (CAJ), are very challenging problems to treat. Various open and endoscopic surgical approaches have been described to treat PGS, including ablatives techniques such as arytenoidectomy or posterior cordotomy. However, these procedures often sacrifice some of the phonatory function at the expense of glottic airway. More recently, a nonablative approach with excision of the interarytenoid scar and interposition of a postcricoid advancement flap was introduced; however, vocal cord mobility could not be restored in grade 3 or 4 PGS. We report on five patients with a type 4 PGS who were treated using a modified endoscopic technique to restore vocal cord mobility by removing the interand periarytenoid scar, circumferentially incising the CAJs, mobilizing both arytenoids, and reconstructing the interarytenoid area with a rotational advancement mucosal flap from the medial piriform sinus.


Clinical Otolaryngology | 2018

Improved exposure of the hypoglossal branches during hypoglossal nerve stimulator implantation: Clinical outcomes of twenty patients at a single institution

Mark Weidenbecher; Akina Tamaki; Claudia Cabrera; Kingman P. Strohl

This retrospective study examined 20 patients who underwent hypoglossal nerve stimulation implantation for treatment of obstructive sleep apnea at a single institution. We utilized a modification in standard surgical technique allowing improved visualization of the distal hypoglossal nerve. Main outcome and measures included apnea hypoxia index, oxygen desaturation index, mean and minimum saturation and percentage of time below 90% saturation. We examined operative time and adverse events. Epworth Sleepiness Score and post-operative questionnaires was used to assess subjective measures of outcome. Our outcomes favorably compare to previously reported HNS outcomes and highlights the importance of optimal visualization of the hypoglossal nerve distal branches. This article is protected by copyright. All rights reserved.


American Journal of Otolaryngology | 2016

Adult onset xanthogranuloma presenting as laryngeal mass

Shawn Li; Mark Weidenbecher

Histiocytic disorders can be classified according to the distribution pattern of the lesions and the organs involved. Non-Langerhans-cell histiocytosis is a rare group of diseases that have varied clinical presentations ranging from isolated masses to diffuse systemic eruptions. We discuss a patient who initially presented with a vocal cord lesion and was ultimately diagnosed with adult onset xanthogranuloma.

Collaboration


Dive into the Mark Weidenbecher's collaboration.

Top Co-Authors

Avatar

James E. Dennis

Benaroya Research Institute

View shared research outputs
Top Co-Authors

Avatar

Amad Awadallah

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Kingman P. Strohl

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Harvey M. Tucker

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Jonathan Z. Baskin

University Hospitals of Cleveland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B.A. Madeleine Strohl

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Cliff A. Megerian

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Colin Huntley

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Colleen Lance

Case Western Reserve University

View shared research outputs
Researchain Logo
Decentralizing Knowledge